Latest Breaking News On - Joyce allaire - Page 17 : comparemela.com

Larimar Therapeutics Announces Proposed Underwritten Public Offering

Larimar Therapeutics Announces Proposed Underwritten Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkJoyce allaireMichael celanoBroadridge financial solutionsEquity syndicate departmentAboutlarimar therapeutics incLeerink partnersSyndicate departmentGuggenheim securitiesCompany contactLarimar therapeutics incExchange commissionSci capitalIsland avenueLarimar therapeutics

Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference

Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesLauren walkerAlex grayJoyce allaireCompany investor relationsJasper therapeutics incAnnual healthcareAnnual healthcare conferenceInvestor relationsAnnual reportQuarterly reports

TScan Therapeutics Expands Clinical Team with the Appointment of Dawn Pinchasik, M D , M S , as Vice President, Clinical Development

WALTHAM, Mass., Feb. 06, 2024 TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment.

United statesUniversity of cincinnatiDebora bartonJoyce allaireHeather savelleLife edit therapeutics incTranslational researchAmgen incGlobe newswire tscan therapeutics incOnyx pharmaceuticals incEarly development at elevatebioRubius therapeutics incClinical developmentDrexel university college of medicineLifesci advisorsSecurities exchange

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

REDWOOD CITY, Calif., Feb. 06, 2024 Jasper Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit to address diseases such.

New yorkUnited statesAlex grayLauren walkerJoyce allaireEvercore groupExchange commissionGreat point partnersGlobenewswire incJasper therapeutics incChronic inducible urticariaAvidity partnersPoint partnersVenture partners united statesSprings capitalSamsara biocapital

Jasper Therapeutics, Inc Reports Inducement Grants Under

REDWOOD CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on.

United statesLauren walkerJoyce allaireAlex grayJasper therapeutics incEach optionJasper therapeuticsEquity incentive planNasdaq listing ruleAnnual reportQuarterly reportsNasdaq jsprJasper therapeutics